Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • Toolbox: Coding and Computation
      • Toolbox: Signatures and Cells
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity

Anat Globerson Levin, Moran Rawet Slobodkin, Tova Waks, Galit Horn, Lihi Ninio-Many, Naamit Deshet Unger, Yaara Ohayon, Shimrit Suliman, Yael Cohen, Boris Tartakovsky, Ella Naparstek, Irit Avivi and Zelig Eshhar
Anat Globerson Levin
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
2Weizmann Institute of Science, Rehovot, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: anatgl@tlvmc.gov.il
Moran Rawet Slobodkin
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tova Waks
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
2Weizmann Institute of Science, Rehovot, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Galit Horn
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lihi Ninio-Many
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naamit Deshet Unger
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaara Ohayon
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yaara Ohayon
Shimrit Suliman
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yael Cohen
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boris Tartakovsky
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Boris Tartakovsky
Ella Naparstek
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irit Avivi
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zelig Eshhar
1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
2Weizmann Institute of Science, Rehovot, Israel.
3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/2326-6066.CIR-20-0118 Published December 2020
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: October 2020 to March 2021

AbstractFull-text HTMLPDF
Total2532190368

Cited By

Article Information

Volume 8, Issue 12, pp. 1485-1495

DOI 
https://doi.org/10.1158/2326-6066.CIR-20-0118
PubMed 
33008840

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received February 6, 2020
  • Revision received August 4, 2020
  • Accepted September 29, 2020
  • Published first October 2, 2020.

Article Versions

  • Previous version (October 2, 2020 - 05:39).
  • Previous version (November 5, 2020 - 05:54).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2020 American Association for Cancer Research.

Author Information

  1. Anat Globerson Levin1,2,#,*,
  2. Moran Rawet Slobodkin1,#,
  3. Tova Waks1,2,
  4. Galit Horn1,
  5. Lihi Ninio-Many1,
  6. Naamit Deshet Unger1,
  7. Yaara Ohayon1,
  8. Shimrit Suliman1,
  9. Yael Cohen1,3,
  10. Boris Tartakovsky1,
  11. Ella Naparstek1,
  12. Irit Avivi1,3, and
  13. Zelig Eshhar1,2,3
  1. 1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
  2. 2Weizmann Institute of Science, Rehovot, Israel.
  3. 3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  1. ↵*Corresponding Author:
    Anat Globerson Levin, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv 6423906, Israel. Phone: 972-3-6972503; Fax: 972-3-697-2549; E-mail: anatgl{at}tlvmc.gov.il
  1. ↵#Note: A. Globerson Levin and M. Rawet Slobodkin contributed equally to this article.

View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 8 (12)
December 2020
Volume 8, Issue 12
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity
Anat Globerson Levin, Moran Rawet Slobodkin, Tova Waks, Galit Horn, Lihi Ninio-Many, Naamit Deshet Unger, Yaara Ohayon, Shimrit Suliman, Yael Cohen, Boris Tartakovsky, Ella Naparstek, Irit Avivi and Zelig Eshhar
Cancer Immunol Res December 1 2020 (8) (12) 1485-1495; DOI: 10.1158/2326-6066.CIR-20-0118

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity
Anat Globerson Levin, Moran Rawet Slobodkin, Tova Waks, Galit Horn, Lihi Ninio-Many, Naamit Deshet Unger, Yaara Ohayon, Shimrit Suliman, Yael Cohen, Boris Tartakovsky, Ella Naparstek, Irit Avivi and Zelig Eshhar
Cancer Immunol Res December 1 2020 (8) (12) 1485-1495; DOI: 10.1158/2326-6066.CIR-20-0118
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Machine Learning–Based Prognostic Marker of HCC
  • Lenalidomide Turns Myeloma-Associated Macrophage Tumoricidal
  • Inflammasome-Independent IL1β Inhibits Antitumor Immunity
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement